Inventor · disambiguated record
Annabelle Biscans
Also filed as: BISCANS ANNABELLE
4 granted patents·7 pending applications·18 citations·filing 2017–2024
71Inventor score
Files withUNIV MASSACHUSETTS11
Top patents by PatentIndex Score
11 records- 0194US11702659B2Optimized anti-FLT1 oligonucleotide compounds for treatment of preeclampsia and other angiogenic disordersUNIV MASSACHUSETTS·Filed 2022·Granted Jul 18, 2023·9 cites·30 claims
- 0289US11753638B2Conjugated oligonucleotidesUNIV MASSACHUSETTS·Filed 2017·Granted Sep 12, 2023·7 cites·18 claims
- 0384US12077758B2Oligonucleotides for SARS-CoV-2 modulationUNIV MASSACHUSETTS·Filed 2021·Granted Sep 3, 2024·2 cites·18 claims
- 0472US2024067967A1Optimized anti-flt1 oligonucleotide compounds for treatment of preeclampsia and other angiogenic disordersUNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 0570US2024084297A1Conjugated oligonucleotidesUNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 0668US2024425860A1OLIGONUCLEOTIDES FOR SARS-CoV-2 MODULATIONUNIV MASSACHUSETTS·Filed 2024·Application pending·0 cites
- 0767US12365894B2Branched lipid conjugates of siRNA for specific tissue deliveryUNIV MASSACHUSETTS·Filed 2020·Granted Jul 22, 2025·0 cites·17 claims
- 0862US2024352459A1Compositions and methods for sirna treatment of muscular dystrophyUNIV MASSACHUSETTS·Filed 2022·Application pending·0 cites
- 0962US2024182904A1Oligonucleotides targeting s6k1UNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 1060US2024173420A1Ocular delivery of oligonucleotidesUNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 1155US2022042015A1Conjugated oligonucleotides for tissue specific deliveryUNIV MASSACHUSETTS·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Annabelle Biscans files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →